{"authors": [["Esmaeili", "Mohammad Hossein", "MH", "Cellular and Molecular Research Center & Department of Physiology, Qazvin University of Medical Sciences, Qazvin, Iran."], ["Bahari", "Behnam", "B", "Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Salari Institute of Cognitive and Behavioral Disorders (SICBD), Alborz, Iran."], ["Salari", "Ali-Akbar", "AA", "Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Salari Institute of Cognitive and Behavioral Disorders (SICBD), Alborz, Iran. Electronic address: aa.salari@yahoo.com."]], "doi": "10.1016/j.brainresbull.2018.01.001", "date": "2018-01-16_23:18:13", "journal": ["Brain research bulletin", "Brain Res. Bull."], "year": null, "title": "ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease.", "id": "29307659", "text": ["affective", "disorders", "including", "depression", "anxiety", "among", "prevalent", "behavioral", "abnormalities", "patients", "alzheimer", "disease", "ad", "affect", "quality", "life", "progression", "disease", "dysregulation", "hpa", "axis", "reported", "affective", "disorders", "ad", "recent", "studies", "revealed", "current", "antidepressant", "drugs", "completely", "effective", "treating", "disorders", "people", "dementia", "katp", "channels", "involved", "ad", "pathophysiology", "hpa", "axis", "function", "pathogenesis", "depression", "behaviors", "thus", "targeting", "katp", "channel", "may", "potential", "therapeutic", "strategy", "ad", "hence", "investigated", "effects", "intracerebroventricular", "injection", "alone", "combination", "glibenclamide", "katp", "channel", "inhibitor", "behaviors", "well", "hpa", "axis", "response", "stress", "rats", "rats", "orally", "treated", "glibenclamide", "behavioral", "consequences", "assessed", "using", "sucrose", "preference", "forced", "swim", "box", "plus", "maze", "tests", "corticosterone", "levels", "following", "forced", "swim", "plus", "maze", "tests", "also", "evaluated", "indicative", "abnormal", "induced", "hpa", "axis", "hyperreactivity", "increased", "symptoms", "rats", "results", "showed", "blockade", "katp", "channels", "glibenclamide", "decreased", "behaviors", "normalizing", "hpa", "axis", "activity", "rats", "study", "provides", "additional", "evidence", "a\u03b2", "administration", "induce", "symptoms", "rodents", "suggests", "katp", "channel", "inhibitors", "may", "plausible", "therapeutic", "strategy", "treating", "affective", "disorders", "ad", "patients"]}